IKBKB and neuroblastoma: MTT assays showed that overexpression of IKKβ could significantly attenuate the anticancer effect of miR-429 in SH-SY5Y and SK-N-SH cells (Fig. 5g and h), suggesting that miR-429 inhibited the proliferation of neuroblastoma cells in part by targeting IKKβ.